The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3

Por um escritor misterioso
Last updated 11 junho 2024
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a long tradition and wide readership, IMR Press is dedicated to making positive contributions to academics, corporate libraries as well as to readers and authors. All the editors in IMR Press will provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardiorenal syndrome: long road between kidney and heart
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Diagnostics, Free Full-Text
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardiorenal syndrome classification system
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
JCM, Free Full-Text
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Progress and Challenges of Understanding Cardiorenal Syndrome Type 3
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Type 4 cardiorenal syndrome Revista Portuguesa de Cardiologia
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardiorenal protection of SGLT2 inhibitors—Perspectives from
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Anemia of cardiorenal syndrome - Kidney International Supplements
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Hypoxia and chronic kidney disease - eBioMedicine
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Frontiers Toward Human Models of Cardiorenal Syndrome in vitro
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Acute Cardiorenal Syndrome: Epidemiology, Pathophysiology
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Acute cardiorenal syndrome: Mechanisms and clinical implications

© 2014-2024 khosatthep.net. All rights reserved.